Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$8,342,116
+$1,465,518 QoQ
Shares Held
33,151
+4.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
#1,015
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Legacy Private Trust Co. holds $43,660,786 across 7 Drug Manufacturers - General names. ABBV ranks #3 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
18,088 | $21,695,290 | |
| 2 | JNJ |
Johnson & Johnson
|
36,303 | $9,219,871 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
33,151 | $8,342,116 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,709 | $2,147,106 | |
| 5 | AMGN |
Amgen Inc
|
4,257 | $1,541,544 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,655 | $441,081 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,167 | $273,778 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,342,116 | 33,151 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $6,876,598 | 31,618 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $7,139,169 | 31,245 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $7,193,252 | 31,067 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $5,613,704 | 30,243 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $5,241,561 | 25,017 | Shares | Sole | 2025-04-04 | |
| 2024-12-31 | $4,480,883 | 25,216 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $4,798,961 | 24,301 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $3,521,477 | 20,531 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $3,702,275 | 20,331 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $3,245,846 | 20,945 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $3,139,203 | 21,060 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,934,823 | 21,783 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $3,418,167 | 21,448 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,561,399 | 22,037 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,956,109 | 22,026 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,521,148 | 22,990 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,804,235 | 23,467 | Shares | Sole | 2022-04-11 | |
| 2021-12-31 | $3,176,077 | 23,457 | Shares | Sole | 2022-01-12 | |
| 2021-09-30 | $2,544,869 | 23,592 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $2,698,854 | 23,960 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $3,145,955 | 29,070 | Shares | Sole | 2021-04-09 | |
| 2020-12-31 | $3,590,596 | 33,510 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,202,553 | 36,563 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $3,737,025 | 38,063 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $2,632,364 | 34,550 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||